NASDAQ:GMDAQ

Gamida Cell (GMDAQ) Stock Price, News & Analysis

$0.02
+0.00 (+3.70%)
(As of 03:28 PM ET)
Today's Range
$0.0142
$0.0186
50-Day Range
N/A
52-Week Range
$0.01
$2.51
Volume
186,661 shs
Average Volume
7.93 million shs
Market Capitalization
$2.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Gamida Cell

Gamida Cell Ltd. is a biopharmaceutical company. It focuses on developing cell therapies to cure cancer and rare and serious hematologic diseases. The company's product pipeline consists of NiCord and NAM-NK which are in clinical stage. It operates primarily in the United States, the European Union and internationally. Gamida Cell Ltd. is headquartered in Jerusalem, Israel.

GMDAQ Stock Price History

GMDAQ Stock News Headlines

Gamida Cell Ltd.
See More Headlines
Receive GMDAQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gamida Cell and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/27/2024
Today
4/30/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:GMDAQ
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-63,000,000.00
Pretax Margin
-3,531.17%

Debt

Sales & Book Value

Annual Sales
$1.78 million
Book Value
($0.02) per share

Miscellaneous

Free Float
143,699,000
Market Cap
$2.50 million
Optionable
Optionable
Beta
0.94
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

GMDAQ Stock Analysis - Frequently Asked Questions

How have GMDAQ shares performed in 2024?

Gamida Cell's stock was trading at $0.0151 at the start of the year. Since then, GMDAQ shares have increased by 11.3% and is now trading at $0.0168.
View the best growth stocks for 2024 here
.

How were Gamida Cell's earnings last quarter?

Gamida Cell Ltd. (NASDAQ:GMDAQ) issued its earnings results on Wednesday, March, 27th. The company reported ($0.04) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.13) by $0.09. The firm had revenue of $1.11 million for the quarter, compared to analyst estimates of $1.21 million.

How do I buy shares of Gamida Cell?

Shares of GMDAQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:GMDAQ) was last updated on 4/30/2024 by MarketBeat.com Staff

From Our Partners